Pancreatic cancer-melanoma syndrome, also known as familial atypical multiple mole melanoma (FAMMM) syndrome, is a condition characterized by an increased risk of developing melanoma and pancreatic cancer. This syndrome is primarily associated with mutations in the CDKN2A gene. Understanding the symptoms and genetic predispositions of this syndrome is crucial for early detection and management. DNA […]











